ABPI APPLIES FOR JUDICIAL REVIEW AGAINST NHS AND NICE

摘要

The Association of the British Pharmaceutical Industry (ABPI) has confirmed that it has applied for a judicial review to challenge a decision made by NHS England and the National Institute for Health and Care Excellence (NICE) to introduce an additional negotiation process for medicines that are likely to cost the NHS more than ￡20m in any of the first three years of use.